Protein phosphatase 1 alpha (PP1α) belongs to the protein phosphatase 1 (PP1) family, which is a group of serine/threonine-specific phosphatases widely expressed in eukaryotic cells. These phosphatases play essential roles in a variety of cellular processes by dephosphorylating many key regulatory proteins. The act of dephosphorylation by PP1s, including PP1α, counterbalances the activities of kinases and ensures the tight regulation of phosphorylation homeostasis within the cell. PP1α, in particular, is involved in multiple cellular pathways, such as glycogen metabolism, cell cycle progression, muscle contraction, and protein synthesis. The specificity of PP1α towards its plethora of substrates is governed by a diverse range of regulatory proteins that bind to it, directing the phosphatase to its appropriate target and modulating its activity.
PP1α inhibitors are molecules that specifically hinder the enzymatic activity of PP1α. These inhibitors typically function by interacting with the catalytic or regulatory domains of the enzyme, preventing it from binding to or dephosphorylating its substrates. Because PP1α plays a critical role in numerous cellular processes, its inhibition can lead to significant alterations in cellular physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thiacloprid | 111988-49-9 | sc-229451 | 100 mg | $112.00 | 3 | |
Tautomycin is a potent and selective inhibitor of PP1α. It binds to the active site and inhibits its phosphatase activity, which may lead to changes in its expression or stability. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits PP1α by binding to its catalytic subunit. Continuous inhibition might affect the stability or expression of PP1α in cells. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of PP1α and PP2A. By blocking the activity of PP1α, it can potentially affect its expression levels. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits both PP1α and PP2A. Persistent inhibition could affect the stability or expression of PP1α. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall inhibits PP1α activity. Continuous exposure to endothall might impact PP1α expression levels. | ||||||
Norcantharidin | 29745-04-8 | sc-280719 | 5 g | $113.00 | 2 | |
Norcantharidin is a demethylated analog of cantharidin and inhibits PP1α. This inhibition could potentially affect PP1α expression. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide affects multiple cellular pathways and has been shown to inhibit PP1α indirectly. This could lead to reduced expression or stability of PP1α. | ||||||
Sodium perchlorate, anhydrous | 7601-89-0 | sc-203398 sc-203398A sc-203398B | 100 g 500 g 2.5 kg | $66.00 $204.00 $627.00 | ||
Perchlorate affects thyroid function and indirectly affects PP1α activity. This might impact its expression levels in certain contexts. | ||||||